Creo granted foundational patent for production of cannabinoids
June 30, 2021 09:00 ET
|
Creo
Creo granted foundational patent for production of cannabinoids Patent covers advantaged method of producing essential precursor for all cannabinoids, creating the foundation for Creo’s IP position ...
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
June 29, 2021 07:00 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company developing cannabinoid-based...
Lifted Made, a Subsidiary of Acquired Sales Corp. (OTCQX: AQSP), Signs an Agreement With Nepa Wholesale Inc. for Exclusive Distribution in Florida of New Urb Finest Flowers Brand Custom Disposable Devices Containing Hemp-Derived Cannabinoids That Could Generate Up to $19,656,000 in Gross Revenue Over a Three Year Period
June 21, 2021 07:00 ET
|
Acquired Sales Corp.
JACKSONVILLE, Fla., June 21, 2021 (GLOBE NEWSWIRE) -- Acquired Sales Corp. (OTCQX: AQSP) today announced that its wholly owned subsidiary Lifted Made, Kenosha, Wisconsin (www.LiftedMade.com) has...
InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with IntegraSyn™ in Advance of Commercial Scale Production
June 17, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
5 g/L cannabinoid yield significantly exceeds reported industry yieldsSignificantly reduces the overall cost of rare cannabinoid manufacturingContinued advancement to GMP-ready large-scale batch...
Grapefruit USA, Inc. Issues Further Update Concerning Formation of Joint Venture with Canadian Partner to Distribute Hourglass Products; Possible Acquisition
May 20, 2021 06:00 ET
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere, fully licensed...
InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa
April 28, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
Filings submitted in Austria, Israel, and Serbia for a Phase 2 Clinical Trial with INM-755 creamAdditional submissions slated for France, Germany, Greece, and Italy over the next several days and...
InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™
April 26, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...
Green Hygienics Holdings Inc. (GRYN) Closes on Acquisition of Two CBD Cigarette Brands
April 20, 2021 13:59 ET
|
Green Hygienics Holdings Inc.
SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") announces today the successful completion of its...
Real Brands Inc. CEO Discusses Corporate Goals and Resolve in Audio Interview with SmallCapVoice.com
April 14, 2021 08:00 ET
|
Real Brands, Inc.
AUSTIN, Texas, April 14, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Thom Kidrin, CEO of Real Brands Inc. (OTCPK: RLBD) (“the...
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test
March 29, 2021 08:30 ET
|
XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...